Circulating endothelin-1 levels in patients with COPD

N. Kubysheva, L. Postnikova, M. Boldina (Nizhny Novgorod, Russian Federation)

Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Session: COPD and asthma - from the cell to the clinic
Session type: E-Communication Session
Number: 4482
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kubysheva, L. Postnikova, M. Boldina (Nizhny Novgorod, Russian Federation). Circulating endothelin-1 levels in patients with COPD. Eur Respir J 2009; 34: Suppl. 53, 4482

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma endothelin-1 levels in septic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 167s
Year: 2006

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Serum leptin levels in patients with chronic airway diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Circulating levels of IGF-I and IGFBP-3 in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015


Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005

Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018




Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002

Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Serum levels of proangiogenic factors before and after the correction of severe hypoxemia in COPD patients
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Role of serum adiponectin in COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008

The effects of high-flow oxygen on plasma endothelin-1 levels during exercise in advanced COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 403s
Year: 2006

Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007